A partnership between Omani and Qatari healthcare institutions will be addressed with a focus on diabetes prevention and treatment. Muscat Daily met with Dr Javaid Sheikh, dean of Weill Cornell Medical College in Qatar, who presented a paper on ‘The role of academic health systems in improving healthcare of a country: Implications for Oman‘. He said during the recent Oman Health Care Expansion Summit “We have established a center focusing on diabetics, which has basic science, translation and clinical centers with advanced genetics laboratories. We examine diabetic patients by using second generation sequence row to identify genes that cause the disease”.
He added “We have found some of the genes which predispose the Qatari population to diabetics, and plan to identify them in the other GCC countries with the same methods. We are also looking to expand our collaboration with the Ministry of Health in the field of medical research for the benefit of humanity. Being the first center in this part of the world for stem cell study, we are looking at the applications of research. As is already known, we can use stem cells to cure cancer and other diseases, and our research focuses on this aspect”.
A new technology and treatment will be developed after getting the results of the rese-arch to heal cancer and diabetics, and to minimize disabilities arising from heart disease. Dr Sheikh commented “We have initiated a program to predict the gender of the date palm tree for the first time. This will make a big difference in breeding, and will help to find out genetic risk factors as well. We are patenting a few applications that will prevent disease and produce good quality crop, and will be made available very soon. I think Oman has a wonderful five year program in place and the healthcare system is very good. What is needed now is to get to the next step in research. My paper at the summit was on the academic health science system and how we can transform it by bringing in new ideas and models”.